Blindness News and Research

RSS

New insights into retinal growth

Peering at microscopic changes within the retina, scientists in the Department of Ophthalmology at Weill Cornell Medical College in New York City, have discovered a key mechanism driving eye health and eye disease.

12 Sep 2007

GlaxoSmithKline responds to Journal of the American Medical Association articles

GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).

12 Sep 2007

Glaucoma surgery with novel laser device

Prof. Ehud Assia, of Tel Aviv University's Sackler School of Medicine is, quite simply, a rock star in the field of eye surgery.

12 Sep 2007

New gel to treat retinal diseases in development

New research presented at the British Pharmaceutical Conference (BPC) in Manchester shows that a new gel for under the eyelid could provide an innovative way of delivering drugs to treat age-related retinal diseases such as wet macular degeneration - potentially making some invasive eye injections a thing of the past.

11 Sep 2007

Yellow plant pigments may lower risk for age-related eye disease

Consuming higher levels of the yellow plant pigments lutein and zeaxanthin may be associated with a lower risk for age-related macular degeneration, according to a report in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

11 Sep 2007

FDA approves Acambis smallpox vaccine

Acambis plc (Acambis) has announced that the US Food and Drug Administration (FDA) has approved its ACAM2000 (Smallpox (Vaccinia) Vaccine, Live) vaccine for protection against smallpox.

4 Sep 2007

Ivermectin is causing genetic selection in river blindness parasite

Ivermectin, the standard drug for treating river blindness (onchocerciasis), is causing genetic changes in the parasite that causes the disease, according to a new study by Roger Prichard (McGill University, Canada) and colleagues, published on August 30, 2007 in the open-access journal PLoS Neglected Tropical Diseases.

30 Aug 2007

Gamma globulin effective treatment for pinkeye

Gamma globulin, a type of antibody isolated from blood samples that used to be routinely given to health care workers and international travelers to protect them from infectious diseases, is a highly effective treatment for pinkeye with little apparent toxicity, according to a study by researchers at the University of Pittsburgh School of Medicine.

29 Aug 2007

Zinc and macular degeneration link

A team of scientists, including three researchers at George Mason University, found that the mineral zinc could play a role in the development of macular degeneration.

28 Aug 2007

Study looks at salsalate for type 2 diabetes

The University of Illinois at Chicago is one of 16 sites in the United States taking part in the first large-scale study to test a promising approach to lowering blood glucose levels in adults with type 2 diabetes.

24 Aug 2007

Age-related macular degeneration patient receives investigational eye drops

An 88-year-old man at The Methodist Hospital in Houston is one of two patients in the world today to receive an investigational eye drop that may restore sight for those suffering from neovascular (wet) age-related macular degeneration, a major cause of central visual loss and one of the leading causes of blindness in people over 60 in the United States.

17 Aug 2007

MS patients given hope with new vaccine treatment

Canadian researchers have developed a vaccine to stop the progression of multiple sclerosis (MS) and they say encouraging results have already been seen.

14 Aug 2007

Another reason to quit - smoking increases the risk blindness in seniors

Australian researchers say people who smoke are four times more likely to develop age-related macular degeneration (AMD).

14 Aug 2007

New avenues for the treatment of amblyopia

Contrary to accepted dogma, a University of Maryland researcher has developed a method that allows an adult to recover function in an eye that has been damaged and dysfunctional throughout life.

13 Aug 2007

Cause of major subtype of glaucoma discovered

In a paper published in the journal Science, scientists from deCODE genetics and academic colleagues from the National University Hospital in Reykjavik and Uppsala University in Sweden report the discovery of two common single letter variations (SNPs) in the sequence of the human genome that appear to account for virtually all cases of a major subtype of glaucoma.

12 Aug 2007

New Alzheimer's drugs may help prevent glaucoma

British eye specialists have shown for the first time that key proteins involved in Alzheimer's disease are also implicated in glaucoma.

8 Aug 2007

Nanotech sensors and tiny transmitters to predict and prevent epileptic seizures

Purdue University researchers have developed new miniature devices designed to be implanted in the brain to predict and prevent epileptic seizures and a nanotech sensor for implantation in the eye to treat glaucoma.

8 Aug 2007

Staffordshire screening programme on track to screen over 35,000 diabetes patients

The Staffordshire Diabetic Retinopathy Screening Service, a community based digital eye screening programme designed to detect and treat diabetic retinopathy, the leading cause of blindness in the developed world, is on track to exceed its target of screening over 35,000 diabetes patients this year.

7 Aug 2007

New understanding of Leber congenital amaurosis

People suffering from a severe retinal disease will sooner or later lose their eyesight considerably or even become completely blind.

7 Aug 2007

Link identified between Alzheimer's disease and glaucoma

UK scientists have shown for the first time that key proteins involved in Alzheimer's disease are also implicated in glaucoma, the major cause of irreversible blindness worldwide.

7 Aug 2007